Pearsanta Secures $1M to Pioneer Data-Driven, Precision Medical Diagnostics

Pearsanta™, Inc. is thrilled to announce a major milestone in our journey to revolutionize healthcare—raising $1,000,000 in our latest funding round. This infusion of capital not only reinforces our commitment to delivering “health by the numbers” but also accelerates our mission to transform medical diagnostics using personalized, data-driven solutions. With our patented technology at the forefront, Pearsanta is uniquely positioned to advance the science of biosample collection and processing, ensuring that providers and patients receive actionable insights for achieving optimal health and wellness. Our existing commercialization infrastructure, anchored by a CLIA-certified, CAP-accredited monitoring center, is set to play a pivotal role as we roll out our innovative diagnostic tools and monitoring systems across diverse channels and delivery models. The newly raised funds will be strategically deployed to further develop our cutting-edge diagnostic platforms, enhance data analytics capabilities, and expand our operational footprint to reach more healthcare providers and patients. By harnessing the power of personalized data, Pearsanta aims to set a new standard in the early detection and continuous monitoring of health conditions, ultimately driving a paradigm shift in patient care. This funding milestone not only validates our vision and the tangible impact of our solutions but also enables us to accelerate our research and development efforts and bring forward a new era of precision medicine. As we move forward, we remain focused on our goal to positively disrupt healthcare, ensuring that detecting and monitoring health conditions by the numbers becomes the gold standard for optimal health and wellness.